Rapid Evacuation and Access of Cerebral Hemorrhage Trial (NCT06870812)
🩺 Plain-English Summary (8th-Grade Level)
The main purpose of this study is to compare patients with a deep bleed in the brain undergoing surgery to patients receiving routine medical care. The standard treatment involves admission to the Intensive Care Unit (ICU) with close monitoring and blood pressure control. It also includes other medical (non-surgical) treatments to prevent more bleeding or another stroke. Sometimes, doctors will recommend surgery to remove the blood if medical treatment alone is not successful. There is evidence that doing minimally invasive surgery early-using a small opening in the skull to remove blood-may help some patients. Researchers aim to understand whether this surgery is better than current medical treatment, which may include surgeries to relieve pressure on the brain in some cases. This study, called REACH, is comparing usual medical care to early minimally invasive surgery so doctors can know which is better for patients.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
- Surgical management (PROCEDURE)
- Medical Management (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (24 Sites)
- University of Alabama at Birmingham — Birmingham, Alabama
- University of Arkansas for Medical Sciences — Little Rock, Arkansas
- Stanford University Medical Center — Palo Alto, California
- Baptist Health Jacksonville FL — Jacksonville, Florida
- Baptist Health South Florida — Kendall, Florida
- University of Miami Health System, Jackson Memorial Hospital — Miami, Florida
- Grady Memorial Hospital — Atlanta, Georgia
- Emory Hospital Midtown — Atlanta, Georgia
- Emory University Hospital (EUH) — Atlanta, Georgia
- RUSH University Medical Center — Chicago, Illinois
- Endeavor Health, Northshore — Evanston, Illinois
- Advocate Aurora Research Institute — Park Ridge, Illinois
- St Vincent Hospital/Goodman Campbell Brain and Spine — Indianapolis, Indiana
- University of Kentucky Health Care, Kentucky Neuroscience Institute — Lexington, Kentucky
- Johns Hopkins School of Medicine — Baltimore, Maryland
- University of Missouri — Columbia, Missouri
- Albany Medical Center — Albany, New York
- SUNY Upstate Medical University — Syracuse, New York
- Montefiore Medical Center/Albert Einstein School of Medicine — The Bronx, New York
- Ohio State University — Columbus, Ohio
- ProMedica Toledo Hospital — Toledo, Ohio
- Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania
- Rhode Island Hospital/Brown University Health — Providence, Rhode Island
- Vanderbilt University Medical Center — Nashville, Tennessee
📞 Contact the Study Coordinator
Phone: (404) 778-1585
Email: alex.hall@emory.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Stroke Hemorrhagic
- The Role of Cognition in Motor Learning After Stroke — Laval, Quebec
Explore by condition: All Stroke Hemorrhagic clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.